Can I take Sorafenib if my liver function is not good?

Not all patients with liver cancer benefit from Sorafenib, the first-line treatment for advanced unresectable hepatocellular carcinoma (HCC), and management of its side effects is improving. Liver cancer is not a single disease. 90% of liver cancer patients suffer from cirrhosis. Even if there is no cirrhosis, liver function damage during treatment must be considered, so the treatment of liver cancer must be considered comprehensively. Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. Many doctors and patients blindly use drugs. When late-stage liver cancer is discovered, sorafenib is used as a life-saving straw. Sorafenib is still taken when severe liver failure occurs, and the effect is naturally unsatisfactory.